findmyKOL
Clinical trialNCT01506596CompletedPhase 2Interventional

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

SponsorVector OncologyEnrollment42LiposarcomaMetastatic LiposarcomaSurgically Unresectable Liposarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sarcoma Oncology Center

    Santa Monica, California, United States

  • Washington Cancer Institute

    Washington D.C., District of Columbia, United States

  • Kootenai Cancer Center

    Post Falls, Idaho, United States

  • Oncology Specialists, Sc

    Niles, Illinois, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Pennsylvania Oncology Hematology Associates

    Philadelphia, Pennsylvania, United States

  • West Clinic

    Memphis, Tennessee, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2012
Primary completion
31 Oct 2014
Completion
31 Mar 2016
Last update posted
15 Feb 2017
Registered enrollment
42
Registry id
NCT01506596

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.